Literature DB >> 18816176

Thyrotoxicosis-induced ventricular arrhythmias.

Powlimi J Nadkarni1, Meeta Sharma, Bruce Zinsmeister, Leonard Wartofsky, Kenneth D Burman.   

Abstract

BACKGROUND: Cardiac arrhythmias associated with thyrotoxicosis tend to be supraventricular in nature with atrial fibrillation being the most common. Ventricular arrhythmias are rarely associated with thyrotoxicosis and are considered to be secondary to intrinsic cardiac disease.
SUMMARY: We present three patients with thyrotoxicosis and stable coronary disease in whom the primary cardiac rhythm disturbance was ventricular tachycardia. In all of these patients, the ventricular arrhythmias terminated with achievement of a euthyroid state. We hypothesize that the thyrotoxic state contributed to the etiology of, or lowered the threshold for the ventricular arrhythmias.
CONCLUSION: Prompt attention to the management of thyrotoxicosis in patients with a history of significant heart disease is warranted in order to avoid potentially fatal arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18816176     DOI: 10.1089/thy.2007.0307

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

1.  Sudden cardiac arrest as a presentation of Brugada syndrome unmasked by thyroid storm.

Authors:  Anna K M Korte; Lennie Derde; Jeroen van Wijk; David H Tjan
Journal:  BMJ Case Rep       Date:  2015-12-30

Review 2.  Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature.

Authors:  Elie Traube; Neil L Coplan
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

4.  Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

5.  Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Circulation       Date:  2019-05-13       Impact factor: 29.690

6.  COMPARISON OF CARDIAC ARRHYTHMIA TYPES BETWEEN HYPERTHYROID PATIENTS WITH GRAVES' DISEASE AND TOXIC NODULAR GOITER.

Authors:  E Turan; I Can; Y Turan; M Uyar; M Cakır
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

Review 7.  Pro-Arrhythmic Signaling of Thyroid Hormones and Its Relevance in Subclinical Hyperthyroidism.

Authors:  Narcis Tribulova; Lin Hai Kurahara; Peter Hlivak; Katsuya Hirano; Barbara Szeiffova Bacova
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

8.  Ventricular fibrillation in Graves disease reveals a rare SCN5A mutation with W1191X variant associated with Brugada syndrome.

Authors:  Kristin Stawiarski; John-Ross D Clarke; Ari Pollack; Robert Winslow; Sachin Majumdar
Journal:  HeartRhythm Case Rep       Date:  2020-11-20

9.  Thyrotoxic Atrial Fibrillation: Factors Associated with Persistence and Risk of Ischemic Stroke.

Authors:  Cheuk-Lik Wong; Ho-Kee Vicki Tam; Chun-Kit Vincent Fok; Pong-Kai Ellen Lam; Lai-Ming Fung
Journal:  J Thyroid Res       Date:  2017-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.